Hasil Pencarian  ::  Simpan CSV :: Kembali

"Glukosamin adalah suatu zat yang dapat disintesis di dalam tubuh yang berguna untuk mempertahankan dan memulihkan kinerja sendi. Seiring bertambahnya usia, kemampuan tubuh untuk mensintesis glukosamin menurun sehingga menyebabkan penyakit osteoartritis. Oleh karena itu, telah berkembang suplemen makanan yang mengandung glukosamin yang telah diakui oleh Food and Drug Administration (FDA) untuk pengobatan osteoartritis. Analisis glukosamin HCl dilakukan untuk memperoleh volume, temperatur, waktu, dan waktu kestabilan reaksi yang optimum pada derivatisasi glukosamin HCl dengan FMOC-Cl menggunakan detektor fluoresensi. Larutan standar glukosamin HCl 1 μg/ml ditambah 50,0 μL 0,2 M dapar dinatrium tetraborat dekahidrat pH 8, kemudian divorteks selama 10 detik, ditambah 360,0 μL pereaksi FMOC-Cl 1 mg/ml, campuran divorteks selama 10 detik, diinkubasi menggunakan termomixer pada 1400 rpm dan temperatur 25°C selama 15 menit, selanjutnya disuntikkan sebanyak 20,0 μL ke alat KCKT. Pemisahan dengan KCKT menggunakan kolom Kromasil® C18 (5 μm; 250 x 4,6 mm) dengan komposisi fase gerak air-asetonitril (40:60) dengan kecepatan alir 1,0 ml/menit. Linieritas pada konsentrasi 100-1000 ng/ml dengan koefisien korelasi (r) 0,9995. Nilai batas deteksi (LOD) sebesar 21,98 ng/ml dan batas kuantitasi (LOQ) sebesar 73,26 ng/ml.

---

Glucosamine is a synthesized substance in the human body useful for maintaining and restoring the joint's function. Body's capacity to synthesize glucosamine declines with age thus can cause osteoarthritis. There was development of dietary supplement that contains glucosamine which has been approved by the Food and Drug Administration (FDA) for treatment of osteoarthritis. Glucosamine HCl analysis was performed in order to get optimal volume, temperature, time, and reaction stability time in glucosamine HCl derivation with FMOC-Cl using fluorescence detector. Standard solution of Glucosamine HCl added by 50.0 μl 0.2 M disodium tetraborate decahydrate buffer with pH 8 were homogenized for 10 seconds, then the mixed solution was added by 360.0 μl of 1 mg/ml FMOC-Cl reagent and homogenized for 10 seconds. It was then incubated using termomixer at 1400 rpm and a temperature of 25°C for 15 minutes, then as many as 20.0 μl injected into the High Performance Liquid Chromatography (HPLC) instrument. Separation by HPLC using one column of Kromasil® C18 (5 μm; 250 x 4.6 mm) with mobile phase composition of water-acetonitrile (40:60) and flow rate 1.0 ml/minute. Linearity at concentrations of 100-1000 ng/ml with a correlation coefficient (r) 0.9995. The limit of detection (LOD) value was 21.98 ng/ml and the limit of quantitation (LOQ) was 73.26 ng/ml."

"Senyawa turunan tiazolidin merupakan senyawa heterosiklik dengan atom nitrogen dan sulfur dalam struktur cincinnya yang dikenal memiliki aktivitas biologis, yaitu antioksidan, antitumor, anti-inflamasi, antimikorba, dan anti-hiperglikemia. Pada penelitian kali ini akan dilakukan sintesis senyawa turunan tiazolidin yang berasal dari 3- asetilpiridin dan memiliki subtituen aldehid aromatik dari senyawa sinamaldehid, benzaldehida, dan 4-hidroksi benzaldehida. Produk senyawa turunan tiazolidin ini diidentifikasi menggunakan KLT dan uji titik leleh, serta dikarakterisasi menggunakan spektrofotometer Ultraviolet-Visible (UV-Vis), Fourier Transform Infrared spectroscopy (FTIR), dan Liquid Chromatography Mass Spectrometry (LC-MS). Senyawa yang terbentuk dilakukan pengujian aktivitas antioksidan dengan menggunakan metode DPPH. Pada penelitian ini didapatkan produk 3-asetilpiridin tiosemikarbazon dengan persen rendemen sebesar 73,83%, 3-asetilpiridin tiazolidin-4-on sebesar 38,39%. turunan 3- asetilpiridin tiazolidin-4-on sinamaldehida sebesar 4,61%, turunan 3-asetilpiridin tiazolidin-4-on benzaldehida sebesar 15,82%, dan turunan 3-asetilpiridin tiazolidin-4-on 4-hidroksi benzaldehida sebesar 21,42%. Kemampuan antioksidan senyawa ditinjau dari nilai IC50 dimana senyawa 3-asetilpiridin tiazolidin-4-on sebesar 452,11 ppm, turunan 3-asetilpiridin tiazolidin-4-on sinamaldehida sebesar 1553,52 ppm, turunan 3- asetilpiridin tiazolidin-4-on benzaldehida sebesar 3484,42 ppm, dan turunan 3- asetilpiridin tiazolidin-4-on 4-hidroksi benzaldehida sebesar 1542,78 ppm.

---

Thiazolidine derivative compounds are heterocyclic compounds with nitrogen and sulfur atom in their ring structure which are known to have biological activities, such as antioxidant, antitumor, anti-inflammatory, antimicrobial, and anti-hyperglycemic. In this study, the synthesis of thiazolidine derivatives derived from 3-acetylpyridine and aromatic aldehyde substituents from cinnamaldehyde, benzaldehyde, and 4-hydroxy benzaldehyde compounds will be carried out. Thiazolidine derivative product was identified using TLC and melting point test, and characterized using Ultraviolet-Visible (UV-Vis) spectrophotometer, Fourier Transform Infrared spectroscopy (FTIR), and Liquid Chromatography Mass Spectrometry (LC-MS). The compounds formed were tested for antioxidant activity using the DPPH method. In this study, 3-acetylpyridine thiosemicarbazone was obtained with a yield 73.83%, 3-acetylpyridine thiazolidine-4- one were 38.39%. the 3-acetylpyridine thiazolidine-4-one derivative of cinnamaldehyde were 4.61%, the 3-acetylpyridine thiazolidine-4-one benzaldehyde derivative were 15.82%, and the 3-acetylpyridine thiazolidine-4-one 4-hydroxy benzaldehyde derivative were 21.42 %. The antioxidant ability of the compound was assessed from the IC50 value where the 3-acetylpyridine thiazolidine-4-one compound was 452.11 ppm, 3- acetylpyridine thiazolidine-4-one derivative of cinnamaldehyde was 1553.52 ppm, 3- acetylpyridine thiazolidine-4-one derivative of benzaldehyde was 3484.42 ppm, and derivatives of 3-acetylpyridine thiazolidine-4-one 4-hydroxy benzaldehyde was 1542.78 ppm."

"Dengue adalah penyakit akut yang disebabkan oleh virus RNA yang termasuk dalam keluarga Flaviviridae. Tujuan penelitian ini adalah untuk mengidentifikasi secara in silico senyawa bahan alam Isoflavon sebagai inhibitor protein NS5 pada virus DENV serotipe 1–4, menganalisis interaksi antara protein NS5 dengan ligan senyawa bahan alam, dan menjelaskan proses farmakokinetika yang meliputi Absorpsi, Distribusi, Metabolisme, dan Ekskresi (ADME) maupun toksisitas pada ligan senyawa bahan alam. Struktur 3-Dimensi protease diperoleh dari situs Research Collaboratory for Structural Bioinformatics Protein Data Bank (RSCB PDB) dan ligan senyawa Isoflavon dari situs PubChem. Penapisan sifat obat terhadap ligan dilakukan melalui perangkat lunak OSIRIS DataWarrior. Simulasi penambatan molekul dilakukan menggunakan protokol rigid dan induced fit docking terhadap protein NS5 menggunakan perangkat lunak Molecular Operating Environment (MOE) 2014.09. Analisis terhadap sifat ADME dan toksisitas obat dilakukan pada perangkat OSIRIS DataWarrior serta situs pkCSM dan SwissADME. Hasil penelitian ini membuktikan bahwa senyawa bahan alam isoflavonoid memiliki potensi untuk menginhibisi protein NS5 DENV berdasarkan nilai ∆Gbinding dan RMSD. Interaksi yang terjadi adalah interaksi ikatan hidrogen dan interaksi cincin aromatik dengan hidrogen. Didapatkan senyawa- senyawa dengan substance identifier (SID) 11655056, 14185735, 6708635, dan 5464170 yang memiliki nilai ∆Gbinding rendah, nilai RMSD di bawah 2 Å, serta sifat farmakokinetik dan kimia medisinal yang baik, dan dianggap dapat berperan sebagai kandidat obat DENV serotipe 1–4 yang baik.

---

Dengue is an acute disease caused by an RNA virus belonging to the Flaviviridae family. The aim of this study is to identify natural compound isoflavone as an in silico inhibitor of the NS5 protein in DENV serotypes 1–4, analyze the interactions between the NS5 protein and isoflavone compound ligands, and elucidate the pharmacokinetic processes, including Absorption, Distribution, Metabolism, and Excretion (ADME), as well as toxicity of the natural compound ligands. The 3-dimensional structure of the protease was obtained from the Research Collaboratory for Structural Bioinformatics Protein Data Bank (RSCB PDB), and isoflavone compound ligands were sourced from PubChem. Drug property screening against the ligands was conducted using OSIRIS DataWarrior software. Molecular docking simulations were performed using rigid and induced fit docking protocols on the NS5 protease using Molecular Operating Environment (MOE) 2014.09 software. Analysis of drug ADME properties and toxicity was carried out using OSIRIS DataWarrior as well as pkCSM and SwissADME websites. The results of this study prove that the natural compound of Isoflavonoids have the potential to inhibit the DENV NS5 protein based on its ∆Gbinding and RMSD values. The interactions that occur are hydrogen bond interactions and aromatic ring interactions with hydrogen. Compounds with substance identifier (SID) 11655056, 14185735, 6708635, dan 5464170 with low ∆Gbinding values, RMSD values below 2 Å, as well as good pharmacokinetic and medicinal chemistry properties were considered as good DENV serotypes 1–4 drug candidate.

"